| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0733-8635(18)30241-9 |
| P698 | PubMed publication ID | 8365030 |
| P2093 | author name string | Gaspari AA | |
| Becker BA | |||
| P2860 | cites work | Pathogenesis of pemphigus erythematosus | Q66881371 |
| Dapsone in the Treatment of Pemphigus Vulgaris | Q67251597 | ||
| Plasma exchange in the treatment of pemphigus vulgaris | Q67286633 | ||
| When and how to use sulfones in bullous diseases | Q67290144 | ||
| Pemphigus Involving the Eyes | Q67348102 | ||
| Pemphigus foliaceus, myasthenia gravis, thymoma and red cell aplasia. A case report and indirect immunofluorescence study on 38 patients with myasthenia gravis | Q67436209 | ||
| Association of pemphigus chronicus with pregnancy | Q67468428 | ||
| Pemphigus of the air and food passages | Q67690347 | ||
| HLA-A10 in pemphigus among Japanese | Q67737152 | ||
| Letter: Gold compounds vs corticosteroids in the treatment of pemphigus vulgaris | Q67806057 | ||
| Pemphigus induced by rifampicin | Q67829839 | ||
| Cephalexin. A nonthiol drug that may induce pemphigus vulgaris | Q67899622 | ||
| Controlled study of plasma exchange in pemphigus | Q67946189 | ||
| Plasmapheresis therapy of pemphigus | Q67946192 | ||
| Postsurgical pemphigus | Q68077301 | ||
| Pemphigus | Q68145720 | ||
| Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus | Q68190980 | ||
| Linear Pemphigus vulgaris along a Surgical Scar | Q68250922 | ||
| A Molecular Basis for MHC Class II—Associated Autoimmunity | Q68355418 | ||
| Treatment of nine cases of pemphigus vulgaris with cyclosporine | Q68415394 | ||
| Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests | Q68465371 | ||
| Pemphigus vulgaris presenting as a nodular lesion | Q68557466 | ||
| The nail fold in pemphigus vulgaris | Q68574749 | ||
| Azathioprine in pemphigus vulgaris | Q68611925 | ||
| Lymphocyte inclusions in newborns of mothers with systemic lupus erythematosus | Q68672374 | ||
| Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies | Q68700146 | ||
| Clinical trial of prostaglandin E2 on the oral lesions of pemphigus vulgaris | Q68750053 | ||
| Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors | Q68809008 | ||
| Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis | Q24561626 | ||
| Cadherins: a molecular family important in selective cell-cell adhesion | Q28249927 | ||
| Plasmapheresis in the management of acute systemic lupus erythematosus? | Q28254677 | ||
| Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia | Q28263500 | ||
| Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion | Q28281922 | ||
| Penicillamine pemphigus and the nephrotic syndrome occurring simultaneously | Q28331678 | ||
| Cadherin cell adhesion receptors as a morphogenetic regulator | Q29620503 | ||
| Therapeutic Plasma Exchange | Q33476216 | ||
| HLA class II allelic variation and susceptibility to pemphigus vulgaris | Q33574546 | ||
| Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase | Q33957769 | ||
| Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice | Q34241125 | ||
| DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. | Q34258531 | ||
| Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris | Q34299348 | ||
| Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region | Q34346951 | ||
| T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex | Q34379715 | ||
| Vesiculobullous mucocutaneous disease: pemphigus vulgaris | Q34517349 | ||
| Pemphigus | Q34537053 | ||
| Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen | Q35586376 | ||
| Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients | Q35586844 | ||
| A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis | Q35591477 | ||
| Phenotypic and functional characterization of T cells from patients with myasthenia gravis | Q35818387 | ||
| Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation | Q36347357 | ||
| Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies | Q36992637 | ||
| Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes | Q37000289 | ||
| Anti-acetylcholine receptor antibodies | Q37000298 | ||
| Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes | Q37015843 | ||
| Pemphigus and Bullous Pemphigoid due to Drugs | Q37093587 | ||
| T helper cell‐dependent B cell activation | Q37106972 | ||
| Drug-induced versus drug-triggered pemphigus | Q37291710 | ||
| Immunopathology of pemphigus | Q37716949 | ||
| Pemphigus in families | Q37775926 | ||
| Esophageal involvement in pemphigus vulgaris: report of two cases and review of the literature. | Q38018333 | ||
| The basis for the immunoregulatory role of macrophages and other accessory cells | Q38174608 | ||
| Pemphigus associated with Castelman's pseudolymphoma. | Q38603047 | ||
| Pemphigus Erythematosus Confined to the Post-Burn Scar | Q54233194 | ||
| Pemphigus vulgaris and internal malignancy. | Q54299363 | ||
| Treatment of pemphigus and pemphigoid with azathioprine. | Q54332337 | ||
| "Bound" complement in the epidermis of patients with pemphigus vulgaris. | Q54407086 | ||
| Deficiency of interleukin-2 production and interleukin-2 receptor expression on peripheral blood leukocytes after phytohemagglutinin stimulation in pemphigus. | Q54483903 | ||
| Nikolsky sign on cervix uteri in pemphigus | Q54726660 | ||
| Pemphigus foliaceus induced by penicillamine | Q54976673 | ||
| Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence: a study of 51 patients | Q57605690 | ||
| Pemphigus Induced by Gold Sodium Thiomalate | Q66831665 | ||
| In vitro complement activation by intercellular antibodies | Q72106387 | ||
| A syndrome of multiple immune autoreactivity. A breakdown in immune regulation | Q72125240 | ||
| Pemphigus: current concepts | Q72126856 | ||
| Pemphigus acantholysis: a unique immunological injury | Q72140650 | ||
| Proteinase activation: a mechanism for cellular dyshesion in pemphigus | Q72140652 | ||
| Pemphigus Vulgaris Involving the Cervix Uteri | Q72217345 | ||
| An Electron Microscopic Study on Pemphigus Vulgaris of the Mouth and the Skin with Special Reference to the Intercellular Cement* | Q72227534 | ||
| Treatment of Pemphigus Vulgaris With Methotrexate | Q72534527 | ||
| Suppressor cell function is preserved in pemphigus and pemphigoid | Q72762968 | ||
| The diagnostic use of monoclonal antibodies in a variety of dermatologic conditions | Q72786982 | ||
| Pemphigus vulgaris with lesions of the rectal mucosa | Q77180385 | ||
| AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS | Q78311227 | ||
| Corticosteroid treatment of pemphigus. Experience with fifty cases over a period of ten years | Q79013447 | ||
| An electron microscopic study of acantholysis in pemphigus vulgaris | Q79107271 | ||
| Blister-spread induced by finger-pressure, a diagnostic sign in pemphigus | Q79138236 | ||
| Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years | Q79441458 | ||
| Familial pemphigus vulgaris with oral manifestations affecting two Greek families | Q38660849 | ||
| Herpes simplex infection associated with pemphigus vulgaris. Case report and literature review | Q38712402 | ||
| Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome | Q39372611 | ||
| Remission of myasthenia gravis following plasma-exchange | Q39413756 | ||
| Pemphigus: a disease of man and animal. Historical and other perspectives | Q39558277 | ||
| HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients | Q39560394 | ||
| Drug-induced pemphigus | Q39583180 | ||
| Gold therapy and its indications in dermatology. A review | Q39764983 | ||
| Pemphigus vulgaris in young Asians--a report of three cases and review of the literature | Q39787102 | ||
| Pemphigus Vulgaris and Lymphoma in a Patient With Scleroderma | Q39818164 | ||
| Pathogenesis of autoimmunity in pemphigus | Q39834086 | ||
| Immunosuppressants in the treatment of pemphigus | Q39991980 | ||
| Juvenile pemphigus | Q40135621 | ||
| HLA and Disease 1982 - A Survey | Q40146426 | ||
| Pemphigus associated diseases and induced pemphigus | Q40205590 | ||
| Immunopathology in pemphigus | Q40205604 | ||
| Azathioprine | Q40316465 | ||
| An organ culture model for the study of pemphigus acantholysis | Q40762873 | ||
| Pemphigus: a survey of 85 patients between 1970 and 1974 | Q40911553 | ||
| Complement-Fixing Pemphigus Antibodies | Q40919018 | ||
| Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes | Q41018374 | ||
| Coexistence of bullous pemphigoid and pemphigus foliaceus | Q41061689 | ||
| The events leading to the death of patients with pemphigus and pemphigoid | Q41142138 | ||
| Gold therapy for pemphigus vulgaris | Q41420995 | ||
| Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus | Q41434622 | ||
| Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris | Q41665144 | ||
| Bradycardia after high-dose intravenous methylprednisolone therapy | Q42223306 | ||
| Azathioprine for pemphigus and pemphigoid--a 4 year follow-up | Q42236049 | ||
| Pemphigus controlled by dapsone | Q42443339 | ||
| Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum | Q42445801 | ||
| Basal cell carcinoma arising in pemphigus vulgaris of the lower eyelid | Q42482724 | ||
| Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes | Q42528603 | ||
| Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin | Q44080725 | ||
| Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up | Q44157159 | ||
| Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines | Q44448632 | ||
| Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris | Q44494670 | ||
| Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder | Q44502161 | ||
| Beau's lines and pemphigus vulgaris | Q44750998 | ||
| Classical and alternate pathway activation of complement in pemphigus vulgaris lesions | Q44810590 | ||
| Treatment of pemphigus | Q44917335 | ||
| Herpetiform pemphigus induced by penicillamine | Q46190146 | ||
| Pemphigus in pregnancy: a reevaluation of fetal risk | Q46377816 | ||
| Sequence analysis of the HLA-DR beta and HLA-DQ beta loci from three Pemphigus vulgaris patients | Q46443297 | ||
| Flourescent antibody studies of pemphigus-like antibodies in burn sera | Q46733438 | ||
| The "pemphigus" antibody and immunopathies affecting the thymus | Q47755478 | ||
| Studies on etiologic factors in pemphigus | Q50535637 | ||
| Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. | Q50911645 | ||
| A case of pemphigus vulgaris in association with Addisonian pernicious anaemia | Q52731422 | ||
| Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions. | Q53573506 | ||
| Electron microscopy and histochemistry of pemphigus and pemphigoid. | Q53780409 | ||
| Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). | Q54023417 | ||
| Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. | Q54035641 | ||
| Pemphigus in an Indian mother and daughter | Q68942206 | ||
| Dapsone as initial treatment in superficial pemphigus. Report of nine cases | Q69012425 | ||
| Pemphigus vulgaris in a 3-and-one-half-year old boy | Q69245619 | ||
| Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid | Q69386351 | ||
| Linear pemphigus vulgaris after X-ray irradiation | Q69393695 | ||
| Pemphigus vulgaris probably induced by penicillin | Q69400689 | ||
| Induction of pemphigus by X-ray irradiation | Q69466736 | ||
| A case of fatal pemphigus vulgaris in association with beta interferon and interleukin-2 therapy | Q69492299 | ||
| Exacerbation of pemphigus by rifampicin | Q69540165 | ||
| Induction of acantholysis in organ explant culture by penicillamine and captopril | Q69547881 | ||
| Phenobarbital-induced pemphigus vulgaris | Q69721214 | ||
| Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma | Q69753973 | ||
| Effects of cyclosporin on bullous pemphigoid and pemphigus | Q69856650 | ||
| Systemic lupus erythematosus with pemphigus vulgaris | Q70047998 | ||
| Pemphigus vulgaris of esophageal mucosa | Q70068523 | ||
| Pemphigus vulgaris in childhood: clinical features, treatment, and prognosis | Q70095401 | ||
| The immunofluorescence findings in Indian pemphigus | Q70104909 | ||
| Esophageal involvement in pemphigus vulgaris: a clinical, histologic, and immunopathologic study | Q70123957 | ||
| The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis | Q70148636 | ||
| Esophagitis dissecans superficialis associated with pemphigus vulgaris | Q70154001 | ||
| Juvenile pemphigus vulgaris | Q70160003 | ||
| Pemphigus vulgaris of the esophagus | Q70217393 | ||
| Pemphigus vegetans presenting with deafness, otalgia and facial nerve paralysis | Q70219968 | ||
| Pemphigus in children | Q70222011 | ||
| Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease | Q70227278 | ||
| Treatment of pemphigus vulgaris with cyclosporine. . | Q70237560 | ||
| Transient acantholytic dermatosis associated with pemphigus foliaceus. Coexistence of two acantholytic diseases | Q70240263 | ||
| Neonatal pemphigus vulgaris | Q70247622 | ||
| Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies | Q70331299 | ||
| Familial occurrence of pemphigus vulgaris | Q70391659 | ||
| Death in pemphigus | Q70483633 | ||
| Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients | Q70510992 | ||
| Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin | Q70511027 | ||
| Pemphigus vulgaris and plasma exchange: clinical and serologic studies | Q70730918 | ||
| Cerebriform tongue—a clinical sign in pemphigus vegetans | Q70787315 | ||
| Correlation of circulating intercellular antibody titres in pemphigus with disease activity | Q71037669 | ||
| Penicillin- and ampicillin-induced pemphigus vulgaris | Q71331516 | ||
| Treatment of hyperkeratotic conditions of the legs with etretinate | Q71394871 | ||
| Pemphigus foliaceus: a case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities | Q71463519 | ||
| Plasma exchange in pemphigus. Uncontrolled study of ten patients | Q71659301 | ||
| Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine | Q71767671 | ||
| Pindolol and hyperthyroidism | Q71836894 | ||
| Maternal pemphigus vulgaris with in vivo bound antibodies in the stillborn fetus | Q71841034 | ||
| Coexisting childhood pemphigus foliaceus and Graves' disease | Q71860871 | ||
| HLA-DRw4 in pemphigus vulgaris patients in Israel | Q71997708 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pemphigus vulgaris | Q3899001 |
| Pemphigus vulgaris | Q10622783 | ||
| P304 | page(s) | 429-452 | |
| P577 | publication date | 1993-07-01 | |
| P1433 | published in | Dermatologic Clinics | Q15758379 |
| P1476 | title | Pemphigus vulgaris and vegetans | |
| P478 | volume | 11 |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q28205009 | Blistering disorders: diagnosis and treatment |
| Q37697899 | Cicatricial changes in ocular pemphigus. |
| Q64996575 | Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology. |
| Q44008361 | Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris |
| Q35242526 | Nanorobotic investigation identifies novel visual, structural and functional correlates of autoimmune pathology in a blistering skin disease model. |
| Q41623831 | Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases |
| Q36184955 | Pemphigus and pregnancy. Analysis and summary of case reports over 49 years |
| Q52730431 | Pemphigus group: overview, epidemiology, mortality, and comorbidities. |
| Q36420611 | Pemphigus vulgaris presenting as gingival involvement. |
| Q35234087 | Pemphigus vulgaris. |
| Q85111576 | Pemphigus vulgaris: effects on periodontal health |
| Q45232277 | Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. |
| Q36692084 | Pregnancy associated with pemphigus |
| Q42092771 | Quantitative analysis of human keratinocyte cell elasticity using atomic force microscopy (AFM). |
| Q41167102 | RECENT TRENDS IN THE MANAGEMENT OF PEMPHIGUS VULGARIS. |
| Q77797504 | The blistering diseases |
| Q37811210 | Vesiculobullous Eruptions of the Oral Cavity |
| Q64046302 | [Familial pemphigus vulgaris: immunogenetic study of HLA class II antigens] |
| Q56899569 | [Pemphigus] |
Search more.